Results Table 21 presents the Week 72 histopathology primary endpoint results comparing WEGOVY injection with placebo on: 1) the estimated percentage of patients with resolution of steatohepatitis and no worsening of liver fibrosis and 2) the estimated percentage of patients with at least one stage improvement in liver fibrosis and no worsening of steatohepatitis
So, if youre wondering, why am I not losing weight on Wegovy?, keep reading to find out the seven most common reasons along with tips and tricks to help you reap the Wegovy benefits again and become a healthier version of you
Head-to-head trial data comparing oral and injectable options is still emerging, and the right choice will depend on individual patient factors including adherence patterns, tolerability, and cost
In contrast, others may only require GLP-1 intermittentlyfor example, every other weekwhile still others may be able to discontinue it completely
Increased risk of tics, uncontrollable twitching, and seizures
Spironolactone should not be taken during pregnancy as it can interfere with the normal development of a male fetus